Northeast Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.74M Buy
4,802
+19
+0.4% +$6.5K 0.06% 96
2026
Q1
$1.68M Buy
4,783
+362
+8% +$129K 0.07% 92
2025
Q4
$1.45M Sell
4,421
-30
-0.7% -$9.52K 0.06% 99
2025
Q3
$1.26M Sell
4,451
-534
-11% -$155K 0.05% 100
2025
Q2
$1.39M Hold
4,985
0.06% 98
2025
Q1
$1.55M Sell
4,985
-154
-3% -$45.5K 0.07% 89
2024
Q4
$1.34M Hold
5,139
0.06% 96
2024
Q3
$1.66M Sell
5,139
-130
-2% -$42.5K 0.07% 91
2024
Q2
$1.65M Sell
5,269
-155
-3% -$45.5K 0.08% 91
2024
Q1
$1.54M Sell
5,424
-58
-1% -$17K 0.08% 90
2023
Q4
$1.58M Sell
5,482
-200
-4% -$54.5K 0.08% 91
2023
Q3
$1.53M Buy
5,682
+250
+5% +$62.4K 0.09% 89
2023
Q2
$1.21M Sell
5,432
-749
-12% -$174K 0.07% 93
2023
Q1
$1.49M Sell
6,181
-207
-3% -$50.8K 0.09% 87
2022
Q4
$1.68M Hold
6,388
0.11% 87
2022
Q3
$1.44M Sell
6,388
-50
-0.8% -$12.1K 0.1% 86
2022
Q2
$1.57M Buy
6,438
+48
+0.8% +$11.8K 0.1% 88
2022
Q1
$1.54M Sell
6,390
-64
-1% -$14.7K 0.08% 95
2021
Q4
$1.45M Sell
6,454
-125
-2% -$26.4K 0.07% 97
2021
Q3
$1.4M Sell
6,579
-382
-5% -$87.9K 0.07% 101
2021
Q2
$1.7M Hold
6,961
0.09% 96
2021
Q1
$1.73M Sell
6,961
-14
-0.2% -$3.34K 0.1% 93
2020
Q4
$1.6M Hold
6,975
0.1% 94
2020
Q3
$1.77M Buy
6,975
+382
+6% +$94.6K 0.12% 82
2020
Q2
$1.55M Hold
6,593
0.12% 80
2020
Q1
$1.34M Buy
6,593
+24
+0.4% +$5.24K 0.12% 83
2019
Q4
$1.58M Sell
6,569
-133
-2% -$29.3K 0.12% 87
2019
Q3
$1.3M Hold
6,702
0.1% 94
2019
Q2
$1.24M Buy
6,702
+2,716
+68% +$486K 0.1% 96
2019
Q1
$757K Sell
3,986
-2
-0.1% -$382 0.06% 101
2018
Q4
$776K Buy
3,988
+433
+12% +$84.5K 0.07% 100
2018
Q3
$737K Sell
3,555
-82
-2% -$16.2K 0.06% 106
2018
Q2
$671K Buy
3,637
+2
+0.1% +$354 0.06% 108
2018
Q1
$620K Hold
3,635
0.05% 106
2017
Q4
$632K Hold
3,635
0.05% 109
2017
Q3
$678K Buy
3,635
+900
+33% +$159K 0.06% 105
2017
Q2
$471K Sell
2,735
-72
-3% -$11.7K 0.04% 118
2017
Q1
$461K Hold
2,807
0.04% 119
2016
Q4
$410K Sell
2,807
-230
-8% -$34.6K 0.04% 123
2016
Q3
$507K Buy
3,037
+1,067
+54% +$180K 0.05% 114
2016
Q2
$300K Hold
1,970
0.03% 130
2016
Q1
$295K Buy
1,970
+600
+44% +$89.1K 0.03% 129
2015
Q4
$222K Buy
+1,370
New +$215K 0.02% 145
2015
Q3
Sell
-1,320
Closed -$203K 158
2015
Q2
$203K Buy
+1,320
New +$211K 0.02% 153

Other funds holding AMGN

Northeast Investment Management's AMGN Position: Q2 2026 in Review

Northeast Investment Management increased its Amgen (AMGN) stake by 0.4% in Q2 2026, buying an estimated $6.5K and bringing the position to 4,802 shares worth $1.74M. The position accounts for 0.06% of the portfolio, ranked #96.

Northeast Investment Management first reported a position in AMGN in Q2 2015 and has held it in 44 quarters since. The position peaked at $1.77M in Q3 2020. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Northeast Investment Management held 4,802 shares of Amgen worth $1.74M as of Q2 2026.
  • Northeast Investment Management bought 19 Amgen shares in Q2 2026, an estimated $6.5K.
  • Amgen made up 0.06% of Northeast Investment Management's portfolio in Q2 2026, its #96 holding.
  • Northeast Investment Management first reported a position in Amgen in Q2 2015 and has held it in 44 quarters since.
  • Northeast Investment Management's Amgen position peaked at $1.77M in Q3 2020.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Northeast Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.